Tag: gene editing industry analysis

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theGene Editing Market?

The increased instances of communicable diseases are driving the growth of the gene editing market, as these editing techniques become critical in diagnosing and curing them. Infectious agents like bacteria, viruses, or parasites cause communicable diseases, which are transmissible from person to person, animals, or the environment. The increasing application of gene editing technologies aids in creating targeted strategies to identify and neutralize pathogens at the genetic level, thus augmenting disease control and prevention initiatives. For example, the World Economic Forum, a non-governmental organization based in Switzerland, revealed in 2023 that infections like influenza and respiratory syncytial virus (RSV) have seen an uptick since the onset of the pandemic. As of February 2023, it was estimated that in the USA, influenza was responsible for about 24 million illnesses, 260,000 hospitalizations, and 16,000 deaths. Furthermore, in 2022, according to the World Health Organization, there were 10.6 million global tuberculosis infections, resulting in 1.3 million deaths. Therefore, the propagation of communicable diseases is a significant factor in the advancement of the gene editing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

#What is the Anticipated CAGR of theGene Editing Market, and What Factors Will Drive It?

The market size for gene editing has experienced rapid expansion in recent years. It is projected to increase from $8.82 billion in 2024 to $10.34 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 17.3%. This surge during the historical period can be traced back to the development of the crispr-cas9 technology, advances in genetic sequencing, innovative medical discoveries, funding for scientific research, and the flourishing biotechnology sector.

In the coming years, the gene editing market is predicted to undergo rapid expansion, with expectations to reach a value of $20.79 billion in 2029, reflecting a compound annual growth rate (CAGR) of 19.1%. The predicted growth during the anticipated period can be credited to factors such as the progress of therapeutic applications, advancements in precision and efficiency, the commercialization of gene therapy, the unfolding of agricultural applications, as well as the expansion of regenerative medicine. Forecasted trends for this period encompass multiplex editing methods, advancements in base editing, gene drives and population alteration, non-viral delivery systems, along with disease simulation and drug discovery.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2486

What Key Market Trends and Innovations Are Shaping the Future of theGene Editing Industry?

Leading businesses in the gene editing market are striving to gain a competitive edge by introducing cutting-edge technology, such as the use of cell-penetrating peptides, which offers potential benefits over existing methods. This innovation could promote the creation of sophisticated cell therapies for treating various diseases, including cancer. In April 2023, for instance, Penn Medicine, a principal multi-hospital healthcare system in the US, discovered that viruses’ protein fragments could effectively and safely transport CRISPR-Cas gene editing molecules into cells and their DNA-rich nucleus. The newly developed technique, the researchers believe, could be instrumental in modifying T cells and other patient-derived cells to create new cell therapies. One such application could be CAR T (chimeric antigen receptor T cell) therapy, a treatment method that uses the patient’s genetically engineered immune cells to combat cancer. This novel genetic engineering approach to cell manipulation can potentially enhance speed, efficiency, and decrease cellular toxicity vis-à-vis existing procedures.

Which Companies Are Leading the Charge in Expanding theGene Editing Market Growth?

Major companies operating in the gene editing market include AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

How is the Global Gene Editing Market Segemented?

The gene editing market covered in this report is segmented –

1) By Technology: CRISPR, TALEN, ZFN

2) By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering

3) By End Users: Biotechnology, Pharmaceutical, Contract Research Organization

Subsegments:

1) By CRISPR: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, CRISPR-based Gene Drives

2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs, Commercial TALEN Kits

3) By ZFN (Zinc Finger Nucleases): Custom ZFNs, Commercial ZFN Kits

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=2486&type=smp

Which Geographics are Influencing the Growth of the Gene Editing Market?

North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Gene Editing Market 2025, By The Business Research Company:

Gastrointestinal Bleeding Treatment Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Pharmaceutical Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report

Endoscopy Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/endoscopy-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the gene editing market grown over the years?

The size of the gene editing market has expanded briskly over the past few years. Its growth is predicted to increase from $8.82 billion in 2024 to $10.34 billion in 2025, with a compound annual growth rate (CAGR) of 17.3%. The expansion during the past period has been driven by factors such as the discovery of CRISPR-Cas9, advancements in genetic sequencing, medical innovations, funding for scientific research, and the growth of the biotechnology industry.

What Is the forecasted market size and growth rate for the gene editing market?

Get your gene editing market report here!

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

What are the major factors driving growth in the gene editing market?

The increasing occurrence of communicable diseases is driving the surge of the gene editing market, as gene editing techniques become vital for diagnosing and treating these diseases. Communicable diseases, which are illnesses spread through infectious agents like bacteria, viruses, or parasites, can be transmitted from person to person, animals, or the environment. Gene editing technologies are being utilized more and more to devise targeted methods capable of identifying and fighting pathogens on a genetic level, thus boosting disease control and prevention strategies. The World Economic Forum, a non-profit organization based in Switzerland, reported in 2023 that infections like influenza and respiratory syncytial virus (RSV) have seen a rise since the outbreak of the pandemic. As of February 2023, the USA recorded approximately 24 million illnesses, 260,000 hospital admissions, and 16,000 deaths due to influenza. Furthermore, in 2022, the World Health Organization revealed that there were 10.6 million tuberculosis infections worldwide, with 1.3 million deaths due to this disease. Consequently, communicable diseases are stimulating the advancement of the gene editing market.

What key areas define the segmentation of the global gene editing Market?

The gene editing market covered in this report is segmented –

1) By Technology: CRISPR, TALEN, ZFN

2) By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering

3) By End Users: Biotechnology, Pharmaceutical, Contract Research Organization

Subsegments:

1) By CRISPR: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, CRISPR-based Gene Drives

2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs, Commercial TALEN Kits

3) By ZFN (Zinc Finger Nucleases): Custom ZFNs, Commercial ZFN Kits

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

What are the top market players propelling the growth of the gene editing industry?

Major companies operating in the gene editing market include AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., Mirus Bio LLC

What are the key trends shaping the future of the gene editing market?

Key players in the gene editing market include AstraZeneca plc, Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare Life Sciences, Agilent Technologies Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., CRISPR Therapeutics, Promega Corporation, GenScript USA Inc., Integrated DNA Technologies Inc., Intellia Therapeutics Inc., DNA Script Inc., Dharmacon Inc., Precision Biosciences Inc., Editas Medicine Inc., OriGene Technologies Inc., Tecan Group Ltd., Sangamo Therapeutics Inc., Horizon Discovery Group plc, Addgene Inc., New England Biolabs Inc., Cellectis SA, Recombinetics Inc., Allele Biotechnology LLC, Transposagen Biopharmaceuticals Inc., Bluebird Bio Inc., Regeneron Pharmaceuticals Inc., Amsbio LLC, Creative Biogene Inc., Synthego Corporation, Beam Therapeutics Inc., Caribou Biosciences Inc., Inscripta Inc., Mammoth Biosciences Inc., Sangon Biotech (Shanghai) Co. Ltd., ToolGen Inc., and Mirus Bio LLC.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2486

What regions are dominating the gene editing market growth?

North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

CRISPR Technology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/crispr-technology-global-market-report

Nuclear Imaging Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nuclear-imaging-devices-and-equipment-global-market-report

Chemicals By End Use Global Market Report 2019 _x000D_

Including: General Chemical Product, Printing Inks, Toiletries, Soap And Cleaning Compounds, Adhesives, Paints And Coatings, Pesticide And Other Agricultural Chemicals, Fertilizer, Synthetic Rubber And Fibers, Plastic Material And Resins, Ethyl Alcohol And Other Basic Organic Chemical, Other Basic Inorganic Chemical, Synthetic Dye And Pigment, Industrial Gas, Petrochemicals , Oil-Based Printing Inks, Solvent-Based Printing Inks, Water-Based Printing Inks , Lotions (Including Sunscreens), Hair Preparations, Face Creams, Perfumes, Shaving Preparations, Other Cosmetic Preparations , Soap And Other Detergent Manufacturing, Surface Active Agent Manufacturing, Polish And Other Sanitation Goods Manufacturing , Water-Based, Solvent-Based, Hot-Melt-Based, Reactive & Others , Water Borne Coatings, Solvent Based Coatings, Powder Coatings, Others – Paints And Coatings , Herbicides, Insecticides, Fungicides, Others – Pesticide And Other Agricultural Chemicals , Nitrogen …

https://www.thebusinessresearchcompany.com/report/chemicals-by-end-use-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR is Anticipated for the Gastrointestinal Devices Market During the Forecast Period, and Why?

The market size for gene editing has seen significant expansion recently. The projection is a rise from $8.82 billion in 2024, to $10.34 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 17.3%. The growth observed in the historic period is due to factors such as the discovery of crispr-cas9, advances in genetic sequencing, groundbreaking medical discoveries, funding for scientific research, and expansion in the biotechnology sector.

The market size for gene editing is anticipated to experience a significant surge in the coming years, ballooning to $20.79 billion in 2029 with a compound annual growth rate (CAGR) of 19.1%. The predicted expansion during the forecast period may be due to the proliferating therapeutic applications, improvements in precision and efficiency, commercialization of gene therapy, development of agricultural applications, and growth of regenerative medicine. Key trends during the forecast period will likely include multiplex editing techniques, innovations in base editing, gene drives and population modification, non-viral delivery systems, as well as disease modeling and drug discovery.

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Market?

Increasing instances of communicable diseases are driving the growth of the gene editing market, as these techniques become instrumental for identifying and treating such illnesses. Communicable diseases, which can be spread from humans to other humans, animals, or even the environment, are caused by infectious agents like bacteria, parasites, and viruses. As a result, gene editing technologies are finding greater use in the creation of focused strategies, aimed at identifying and battling pathogens on a genetic level. This has facilitated both disease prevention and management. As reported by the World Economic Forum in 2023, a non-governmental organization located in Switzerland, infections such as respiratory syncytial virus (RSV) and influenza have seen a rise post-pandemic. The US saw an estimate of 24 million illnesses, 16,000 deaths, and 260,000 hospitalizations due to influenza, as of February 2023. Moreover, the World Health Organization stated in 2022 that tuberculosis afflicted 10.6 million globally, and was responsible for 1.3 million deaths. Therefore, the role of communicable diseases in propelling the gene editing market is undeniable.

Explore Comprehensive Insights Into The Global Gastrointestinal Devices Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2486&type=smp

Which Companies Are Poised to Shape the Future of the Gastrointestinal Devices Market?

Major companies operating in the gene editing market include:

• AstraZeneca plc_x000D_

• Thermo Fisher Scientific Inc._x000D_

• Merck KGaA_x000D_

• GE Healthcare Life Sciences_x000D_

• Agilent Technologies Inc._x000D_

What Are the Latest Innovations and Trends Influencing the Gastrointestinal Devices Market?

Leading firms in the gene editing markets are pioneering breakthrough technology in gene editing, like a method focused on unique cell-penetrating peptides, which offers benefits over existing techniques and could impart a competitive advantage. This strategy could also drive the creation of enhanced cell treatments for cancer and various diseases. For example, in April 2023, Penn Medicine, a renowned multi-hospital health system in the US, discovered that protein segments utilized by certain viruses to infiltrate cells could also be applied to introduce CRISPR-Cas gene editing molecules into cells and their DNA-loaded nuclei with exceptional efficiency and minimal cellular toxicity. Researchers predict this novel method will be especially beneficial in modifying T cells and other patient’s cells to devise cell therapies. One potential application could be CAR T (chimeric antigen receptor T cell) therapy that employs specially adapted immune cells from a patient to combat cancer. This innovative approach to cell genetic engineering predicts a substantial enhancement in speed, efficiency, and a decrease in cellular toxicity relative to present methods.

Secure Your Global Gastrointestinal Devices Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Which Segments Play a Crucial Role in the Expansion of the Gastrointestinal Devices Market?

The gene editing market covered in this report is segmented –

1) By Technology: CRISPR, TALEN, ZFN

2) By Application: Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering

3) By End Users: Biotechnology, Pharmaceutical, Contract Research Organization

Subsegments:

1) By CRISPR: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, CRISPR-based Gene Drives

2) By TALEN (Transcription Activator-Like Effector Nucleases): Custom TALENs, Commercial TALEN Kits

3) By ZFN (Zinc Finger Nucleases): Custom ZFNs, Commercial ZFN Kits

What Regions Are Contributing Significantly to the Growth of the Gastrointestinal Devices Market?

North America was the largest region in the gene editing market in 2024. Western Europe was the second largest region in the global gene editing market share. The regions covered in the gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Definition of the Gastrointestinal Devices Market Impacting Future Growth?

Gene editing is a technology that allows genetic material to change genetic code at a particular location in a genome. It involves cell line engineering, animal genetic engineering, and plant genetic engineering.

Browse Through More Similar Reports By The Business Research Company:

CRISPR Technology Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/crispr-technology-global-market-report

Nuclear Imaging Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nuclear-imaging-devices-and-equipment-global-market-report

Chemicals By End Use Global Market Report 2019 _x000D_

Including: General Chemical Product, Printing Inks, Toiletries, Soap And Cleaning Compounds, Adhesives, Paints And Coatings, Pesticide And Other Agricultural Chemicals, Fertilizer, Synthetic Rubber And Fibers, Plastic Material And Resins, Ethyl Alcohol And Other Basic Organic Chemical, Other Basic Inorganic Chemical, Synthetic Dye And Pigment, Industrial Gas, Petrochemicals , Oil-Based Printing Inks, Solvent-Based Printing Inks, Water-Based Printing Inks , Lotions (Including Sunscreens), Hair Preparations, Face Creams, Perfumes, Shaving Preparations, Other Cosmetic Preparations , Soap And Other Detergent Manufacturing, Surface Active Agent Manufacturing, Polish And Other Sanitation Goods Manufacturing , Water-Based, Solvent-Based, Hot-Melt-Based, Reactive & Others , Water Borne Coatings, Solvent Based Coatings, Powder Coatings, Others – Paints And Coatings , Herbicides, Insecticides, Fungicides, Others – Pesticide And Other Agricultural Chemicals , Nitrogen …

https://www.thebusinessresearchcompany.com/report/chemicals-by-end-use-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: